Document is current
Any future updates will be listed below
-
Authors
Dusaj, Neville
Papoutsi, Eleni
Hoffman, Katherine L.
Siempos, Ilias I.
Schenck, Edward James
-
Funding
Funding for this research was provided by:
National Institutes of Health (F30HL156496)
Hellenic Foundation for Research and Innovation (Project 80- 1/15.10.2020)
National Heart, Lung, and Blood Institute (K 23 HL151876-01A1)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 18 December 2023
First Online: 2 January 2024
Declarations
:
: The institutional review board at Weill Cornell Medicine approved of this study (#181101976) with a waiver of informed consent. With regard to the usage of data from the ROSE clinical trial, because data would be received in de-identified form from the NHLBI BIOLINCC, the Institutional Review Board of Evangelismos Hospital waived the need for informed consent and approved the study (protocol #210/2023-05-10).
: Not applicable.
: EJS reports fees from Axle informatics outside of the current work all other authors report no competing interests.
